O

Onyvax

50 employees

Onyvax develops cancer therapies that harness the selective power of the immune system to seek out and destroy tumor cells.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Cancer vaccines and prostate cancer

Date founded

1997

Funding rounds raised

Total raised

$15M

from 11 investors over 11 rounds

O

Onyvax raised $15M on May 8, 2006

Investors: 2015 Excalibur Group. Reserved, 3i Group plc, S.R. One Ltd and Alta Berkeley

O

Onyvax raised $15M on November 16, 2000

Investors: 2015 Excalibur Group. Reserved, 3i Group plc, S.R. One Ltd and Alta Berkeley

O

Onyvax raised undisclosed on December 18, 1997

Investors: 3i Group plc, S.R. One Ltd and Alta Berkeley

FAQ